B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)
2 clinical trials · Condition
◉ Watch B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)
| Record | Firm | Date |
|---|---|---|
| Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia (NCT03755947) | Grupo Cooperativo de Hemopatías Malignas | 2018-12-01 |
| Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22 (NCT03185494) | Chinese PLA General Hospital | 2017-08-01 |
Track B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis) automatically
Every clearance here is in the API, with alerts when new ones post.